We are excited to announce that VAXELIS - developed in partnership between Sanofi Pasteur and Merck - is available to purchase through our Sanofi Pasteur agreement. VAXELIS is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to...
Practices who have qualified to receive a rebate from Physicians' Alliance of America (PAA) based on their vaccine purchases will be receiving a check next week. The PAA Vaccine Rebate Program has sent more than $12.2 million to our member practices based on their vaccine...
As of March 15, 2021, all new orders placed for the Liletta IUD will feature a new and improved inserter. The updated inserter features an enhanced slider and other improvements to make the Liletta IUD simpler to use. PAA has an agreement with AbbVie (Allergan) to...
Pre-booking for the 2021-22 flu season is underway. Maximize your savings and delivery guarantee by pre-booking through one of our flu vaccine agreements. Login to review the pre-booking discount information and to learn how to reserve your doses. NOTE: Confirm your order for Sanofi Pasteur's Fluzone Quadrivalent...
PAA members are cordially invited to participate in a LIVE WEBINAR speaker program for SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Implementing SHINGRIX The presentation will focus on implementing SHINGRIX into your practice and will review clinical data, patient and provider resources, and strategies to counsel patients about...
Pre-booking for the 2021-22 flu season is underway. Maximize your savings and delivery guarantee by pre-booking through one of our flu vaccine agreements with GSK, Sanofi Pasteur and Seqirus. Log in to review the pre-booking discount information and to learn how to reserve your doses. You...
GSK and Pfizer have recently collaborated to offer PAA members an opportunity to receive a discount on Prevnar 13 effective January 1, 2021. In addition, practices who participate and are compliant on our GlaxoSmithKline Portfolio agreement, and also maintain 80% market share for Rotarix, are...
Sanofi Pasteur has announced that MenQuadfi™ (Meningococcal [Groups A, C, Y, W] Conjugate Vaccine) has been approved by the FDA for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y. The development of MenQuadfi and the...
Sanofi Pasteur invites you to participate in the educational webcast, Risk, Recognition, and Recommendations to Help Prevent Invasive Meningococcal Disease Caused by Serogroups A, C, W, and Y. Register now for two October dates to learn about the burden of meningococcal disease, the importance of...
Coding and billing for vaccinations can be complicated. Doing it right the first time, and every time, is vital to the success of your immunization goals. It's influenza immunization season again. Sanofi Pasteur invites you to start the season with a thorough review of coding, billing,...